Report cover image

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Mar 29, 2024
Length 98 Pages
SKU # GBDT18743637

Description

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the PTA Peripheral DCB Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall, while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels, and long lesions.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the PTA Peripheral DCB Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTA Peripheral DCB Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTA Peripheral DCB Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

98 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 PTA Peripheral DCB Catheters Overview
4 Products under Development
4.1 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
4.2 PTA Peripheral DCB Catheters - Pipeline Products by Territory
4.3 PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
4.4 PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
4.5 PTA Peripheral DCB Catheters - Ongoing Clinical Trials
5 PTA Peripheral DCB Catheters - Pipeline Products under Development by Companies
5.1 PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
5.2 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
6 PTA Peripheral DCB Catheters Companies and Product Overview
6.1 Acotec Scientific Co Ltd Company Overview
6.1.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 AnGes Inc Company Overview
6.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 AngioCure, Inc. Company Overview
6.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.4 Ascenion GmbH Company Overview
6.4.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.5 Becton Dickinson and Co Company Overview
6.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
6.6 Boston Scientific Corp Company Overview
6.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.7 Cardionovum GmbH Company Overview
6.7.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.8 Chansu Vascular Technologies LLC Company Overview
6.8.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.9 Concept Medical Inc Company Overview
6.9.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.1 Contego Medical LLC Company Overview
6.10.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.11 Cordis US Corp Company Overview
6.11.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
6.12 Dingke Medical Technology (Suzhou) Co Ltd Company Overview
6.12.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 eucatech AG Company Overview
6.13.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
6.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
6.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.15 Lutonix Inc Company Overview
6.15.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
6.16 Medtronic Plc Company Overview
6.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Micell Technologies Inc Company Overview
6.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.18 OrbusNeich Company Overview
6.18.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
6.19 Orchestra BioMed Inc Company Overview
6.19.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Pulsus Medical LLC (Inactive) Company Overview
6.20.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.21 QualiMed Innovative Medizinprodukte GmbH Company Overview
6.21.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.22 Shanghai Easy-Flow Medical Tech Co Ltd Company Overview
6.22.1 Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
6.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.24 SiL Vascular Ltd Company Overview
6.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.25 Spectranetics Corp Company Overview
6.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
6.26 Stemplant LLC Company Overview
6.26.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
6.27 SurModics Inc Company Overview
6.27.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.28 Tailored Medical Devices Inc Company Overview
6.28.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
6.29 TransMed7 LLC Company Overview
6.29.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 Vascular Nanotransfer Technologies Company Overview
6.30.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
6.31 Zhejiang Batai Medical Technology Co Ltd Company Overview
6.31.1 Zhejiang Batai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.32 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6.32.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 PTA Peripheral DCB Catheters- Recent Developments
7.1 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
7.2 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
7.3 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
7.4 Feb 21, 2024: Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the Uae
7.5 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
7.6 Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF 232.27 KB)
7.7 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
7.8 Jan 11, 2024: Biblios Study Full Cohort Results on BTK Lesions Presented at PVI
7.9 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.1 Dec 20, 2023: AnGes Laying Off 110 EmendoBio Employees Three Years After $250 million Acquisition
7.11 Nov 16, 2023: Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
7.12 Nov 16, 2023: Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
7.13 Nov 01, 2023: Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
7.14 Oct 31, 2023: Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23
7.15 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.16 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.17 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
7.18 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
7.19 Sep 14, 2023: BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months
7.2 Sep 01, 2023: MicroPort Endovastec Achieves Its First Clinical Implantation of Reewarm PTX DCB Catheter in Brazil
7.21 Aug 30, 2023: Zylox-Tonbridge's ZENFlow Tiger LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
7.22 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.23 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.24 Aug 07, 2023: MCRA Aids Surmodics in Obtaining FDA Pre-market Approval for Cardiovascular Drug-Coated Balloon
7.25 Jul 21, 2023: Medtronic Statement on the Safety of Paclitaxel Coated Devices to Treat Peripheral Arterial Disease
7.26 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
7.27 Jul 13, 2023: BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon
7.28 Jun 07, 2023: Endovastec Participates in the Congresso International de Cirurgia Endovascular
7.29 May 30, 2023: Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
7.3 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
7.31 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.32 Apr 12, 2023: Medtronic has a layoff in California
7.33 Mar 28, 2023: Surmodics provides regulatory update on its strategy to submit an amended Premarket Approval Application for the SurVeil Drug-Coated Balloon
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
Table 2: PTA Peripheral DCB Catheters - Pipeline Products by Territory
Table 3: PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
Table 4: PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
Table 5: PTA Peripheral DCB Catheters - Ongoing Clinical Trials
Table 6: PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
Table 7: PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
Table 8: Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AcoArt-Litos Drug-Eluting Balloon - Product Status
Table 10: AcoArt-Litos Drug-Eluting Balloon - Product Description
Table 11: AcoArt-Tulip - Product Status
Table 12: AcoArt-Tulip - Product Description
Table 13: Acotec Scientific Co Ltd - Ongoing Clinical Trials Overview
Table 14: AcoArt-Litos Drug-Eluting Balloon - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table 15: AcoArt-Litos Drug-Eluting Balloon - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table 16: AcoArt-Litos Drug-Eluting Balloon - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Table 17: AcoArt-Tulip - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table 18: AcoArt-Tulip - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table 19: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
Table 21: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
Table 22: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: AngioCure TOP-C Smart Balloon Catheter - Product Status
Table 24: AngioCure TOP-C Smart Balloon Catheter - Product Description
Table 25: Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Paclitaxel-Coated Balloon Catheter - Product Status
Table 27: Paclitaxel-Coated Balloon Catheter - Product Description
Table 28: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 29: BD Sirolimus Drug Coated Balloon Catheter - Product Status
Table 30: BD Sirolimus Drug Coated Balloon Catheter - Product Description
Table 31: Becton Dickinson and Co - Ongoing Clinical Trials Overview
Table 32: BD Sirolimus Drug Coated Balloon Catheter - A Prospective, Multicenter, Single Arm, Non-Randomized, Study to Assess the Performance and Safety of BD Sirolimus Drug Coated Balloon Catheter for Treatment of Femoropopliteal Arteries
Table 33: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Status
Table 35: Ranger Paclitaxel-Coated PTA Balloon Catheter - Product Description
Table 36: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 37: Ranger Paclitaxel-Coated PTA Balloon Catheter - Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease (ARTEMIS Trial)
Table 38: Ranger Paclitaxel-Coated PTA Balloon Catheter - Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
Table 39: Ranger Paclitaxel-Coated PTA Balloon Catheter - Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): Real Life Observational Study
Table 40: Ranger Paclitaxel-Coated PTA Balloon Catheter - Ranger Drug-coated Balloon Catheters Post Market Surveillance
Table 41: Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 42: LEGFLOW OTW - Product Status
Table 43: LEGFLOW OTW - Product Description
Table 44: Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Peripheral Everolimus Drug-Coated Balloon - Product Status
Table 46: Peripheral Everolimus Drug-Coated Balloon - Product Description
Table 47: Chansu Vascular Technologies LLC - Ongoing Clinical Trials Overview
Table 48: Peripheral Everolimus Drug-Coated Balloon - A First in-human Study Evaluating the Efficacy of Peripheral Everolimus Drug-coated Balloon in Patients with Peripheral Artery Disease: CVT-SFA
Table 49: Peripheral Everolimus Drug-Coated Balloon - Chansu Vascular Technologies Everolimus-Coated Balloon Percutaneous Transluminal Angioplasty Catheter First-in-Human Clinical Investigation
Table 50: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: MagicTouch PTA Balloon Catheter - Product Status
Table 52: MagicTouch PTA Balloon Catheter - Product Description
Table 53: Concept Medical Inc - Ongoing Clinical Trials Overview
Table 54: MagicTouch PTA Balloon Catheter - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Table 55: MagicTouch PTA Balloon Catheter - Head-to-Head Comparison of Sirolimus Versus Paclitaxel Drug-Eluting Balloon Angioplasty in the Femoropopliteal Artery
Table 56: MagicTouch PTA Balloon Catheter - Major Adverse Limb Events in Patients with Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated with Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
Table 57: MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First SirolimUs Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease: FUTURE BTK
Table 58: MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Superficial Femoral Artery and Popliteal Artery Disease
Table 59: MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of Magictouch - Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Table 60: Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Tibial Artery Drug Eluting Balloon - Product Status
Table 62: Tibial Artery Drug Eluting Balloon - Product Description
Table 63: Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 64: SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Status
Table 65: SELUTION SLR 018 DEB - Peripheral Artery Disease - Product Description
Table 66: Cordis US Corp - Ongoing Clinical Trials Overview
Table 67: SELUTION SLR 018 DEB - Peripheral Artery Disease - Intervention with Selution SLR Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Table 68: SELUTION SLR 018 DEB - Peripheral Artery Disease - Pivotal Clinical Trial for the Treatment of Occlusive Disease of the Superficial Femoral Artery (SFA) Using SELUTION SLR Sirolimus-eluting Balloon
Table 69: SELUTION SLR 018 DEB - Peripheral Artery Disease - SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
Table 70: SELUTION SLR 018 DEB - Peripheral Artery Disease - Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
Table 71: SELUTION SLR 018 DEB - Peripheral Artery Disease - SELUTION SLR 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis
Table 72: SELUTION SLR 018 DEB - Peripheral Artery Disease - SUCCESS (Selution, Safety, Efficacy, Health Economics and Proms) PTA Study
Table 73: Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Dissolve AV - Product Status
Table 75: Dissolve AV - Product Description
Table 76: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Support - Product Status
Table 78: Support - Product Description
Table 79: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 80: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
Table 81: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
Table 82: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table 83: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Table 84: Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Status
Table 86: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Description
Table 87: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 88: IN.PACT Admiral DEB - BTK - Product Status
Table 89: IN.PACT Admiral DEB - BTK - Product Description
Table 90: Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Drug-Coated Balloon - Product Status
Table 92: Drug-Coated Balloon - Product Description
Table 93: OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Limus Drug Coated Balloon - Peripheral - Product Status
Table 95: Limus Drug Coated Balloon - Peripheral - Product Description
Table 96: Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Virtue Sirolimus-Eluting Balloon - BTK - Product Status
Table 98: Virtue Sirolimus-Eluting Balloon - BTK - Product Description
Table 99: Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 5
Table 100: Micro-Perforated Catheter Balloon Drug Delivery System - Product Status 5
Table 101: Micro-Perforated Catheter Balloon Drug Delivery System - Product Description 5
Table 102: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Kinesyx-Based Peripheral Drug Coated Balloon - Product Status
Table 104: Kinesyx-Based Peripheral Drug Coated Balloon - Product Description
Table 105: Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Below-The-Knee Rapamycin Drug Coated Balloon - Product Status
Table 107: Below-The-Knee Rapamycin Drug Coated Balloon - Product Description
Table 108: Shanghai Easy-Flow Medical Tech Co Ltd - Ongoing Clinical Trials Overview
Table 109: Below-The-Knee Rapamycin Drug Coated Balloon - To Evaluate the Safety and Efficacy of Drug-eluting Below-the-knee Balloon Dilatation Catheter in the Treatment of Infrapopliteal Artery Stenosis or Occlusion in a Prospective, Multicenter, Randomized Controlled Clinical Trial
Table 110: Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Rapamycin Drug-Eluting Peripheral Balloon Catheter - Product Status
Table 112: Rapamycin Drug-Eluting Peripheral Balloon Catheter - Product Description
Table 113: SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 114: Peripheral Vascular Balloon - Product Status
Table 115: Peripheral Vascular Balloon - Product Description
Table 116: Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Stellarex 0.014 Over-The-Wire Drug-Coated Angioplasty Balloon - Product Status
Table 118: Stellarex 0.014 Over-The-Wire Drug-Coated Angioplasty Balloon - Product Description
Table 119: Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Peripheral Vascular Angioplasty Delivery Device - Product Status
Table 121: Peripheral Vascular Angioplasty Delivery Device - Product Description
Table 122: SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 123: Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Status
Table 124: Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Description
Table 125: Sundance BTK DCB - Product Status
Table 126: Sundance BTK DCB - Product Description
Table 127: Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 5
Table 128: MR-PEO-DCB - Product Status 5
Table 129: MR-PEO-DCB - Product Description 5
Table 130: TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 6
Table 131: Zeppelin II - Product Status 6
Table 132: Zeppelin II - Product Description 6
Table 133: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Mitomycin-Based Drug Coated Balloon - Peripheral - Product Status
Table 135: Mitomycin-Based Drug Coated Balloon - Peripheral - Product Description
Table 136: Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Status
Table 137: Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Description
Table 138: Zhejiang Batai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 139: Peripherally Constrained Drug Balloon - Product Status
Table 140: Peripherally Constrained Drug Balloon - Product Description
Table 141: Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 142: Second Generation UltraFree Drug Coated PTA Balloon Catheter - Product Status
Table 143: Second Generation UltraFree Drug Coated PTA Balloon Catheter - Product Description
Table 144: Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Status
Table 145: Ultrafree Drug Coated PTA Balloon Catheter - BTK - Product Description
Table 146: Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Status
Table 147: Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Product Description
Table 148: Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Status
Table 149: Ultrafree Drug Coated PTA Balloon Catheter - Vertebral Artery Stenosis - Product Description
Table 150: Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 151: Ultrafree Drug Coated PTA Balloon Catheter - BTK - A Prospective, Multicenter, Randomized Controlled Trail Using Drug-coated Balloon to Treat Below The Knee Arterial Stenosis or Occlusion
Table 152: Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Dialysis Access
Table 153: Glossary 7
2.2 List of Figures
Figure 1: PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
Figure 2: PTA Peripheral DCB Catheters - Pipeline Products by Territory
Figure 3: PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
Figure 4: PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
Figure 5: PTA Peripheral DCB Catheters - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us